about
Clinical proteomics of enervated neuronsOverview of the Diagnostic Methods Used in the Field for Human African Trypanosomiasis: What Could Change in the Next Years?Optimization and evaluation of surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry for protein profiling of cerebrospinal fluid.Proteome analysis of biomarkers in the cerebrospinal fluid of neuromyelitis optica patients.Determination of asialotransferrin in the cerebrospinal fluid with the HPLC method.High-throughput and targeted in-depth mass spectrometry-based approaches for biofluid profiling and biomarker discovery.Central nervous system drug development: an integrative biomarker approach toward individualized medicine.Mass spectrometric analysis of rat cerebrospinal fluid proteins following exposure to the neurotoxicant carbonyl sulfide.Proteome analysis of human aqueous humor.Cerebrospinal fluid interleukin-6 in central nervous system inflammatory diseasesIn vitro effects of fetal rat cerebrospinal fluid on viability and neuronal differentiation of PC12 cells.Spinal Cord Stimulation Alters Protein Levels in the Cerebrospinal Fluid of Neuropathic Pain Patients: A Proteomic Mass Spectrometric Analysis.Sera proteomic biomarker profiling in HIV-1 infected subjects with cognitive impairmentCSF proteomic fingerprints for HIV-associated cognitive impairment.Proteome analysis of human cerebrospinal fluid as a diagnostic biomarker in patients with meningiomaProteomics with a pinch of salt: a cyanobacterial perspectiveMass spectrometry-based proteomics and peptidomics for biomarker discovery in neurodegenerative diseasesBiomarkers of HIV-1 associated dementia: proteomic investigation of sera.Proteomic analysis of traumatic brain injury: the search for biomarkers.Proteomic analysis of cerebrospinal fluid in pneumococcal meningitis reveals potential biomarkers associated with survival.Mass Spectrometry-based Proteomics and Peptidomics for Systems Biology and Biomarker Discovery.2D DIGE of the cerebrospinal fluid proteome in neurological diseases.Application of quantitative proteomics technologies to the biomarker discovery pipeline for multiple sclerosis.Spectral counting assessment of protein dynamic range in cerebrospinal fluid following depletion with plasma-designed immunoaffinity columnsSurvival defects of Cryptococcus neoformans mutants exposed to human cerebrospinal fluid result in attenuated virulence in an experimental model of meningitis.Effect of a trans fatty acid-enriched diet on biochemical and inflammatory parameters in Wistar rats.Stable Isotope Labeling by Amino acid in Vivo (SILAV): a new method to explore protein metabolism.Neural differentiation of human umbilical cord mesenchymal stem cells by cerebrospinal fluid.Cerebrospinal fluid markers to distinguish bacterial meningitis from cerebral malaria in children.Light on a sensory interface linking the cerebrospinal fluid to motor circuits in vertebrates.Melatonin from cerebrospinal fluid but not from blood reaches sheep cerebral tissues under physiological conditions.In Vitro Effects of Wistar Rat Prenatal and Postnatal Cerebrospinal Fluid on Neural Differentiation and Proliferation of Mesenchymal Stromal Cells Derived from Bone Marrow.Cerebrospinal Fluid Concentrations of Biogenic Amines: Potential Biomarkers for Diagnosis of Bacterial and Viral Meningitis.Immunosignature Differentiation of Non-Infectious Meningoencephalomyelitis and Intracranial Neoplasia in Dogs.Potential Use of Amniotic Membrane - Derived Scaffold for Cerebrospinal Fluid ApplicationsThe choroid plexus sodium-bicarbonate cotransporter NBCe2 regulates mouse cerebrospinal fluid pH
P2860
Q26752052-486E8426-EABE-4658-A360-F15D0B8E9CE7Q26778571-04E8C1F1-E7F2-4B51-877A-6F9602EB32F4Q33241392-1F455389-6BB4-41FA-842C-60BB434C4655Q33497345-15FD52E1-EAD3-4FFA-9F29-745075A5772DQ33523864-C427FDEC-0946-4E78-9940-859989F5CF27Q33579375-71E4F0A2-A62D-4BA1-899B-56A67B10C48BQ33947007-BA944EB5-70E3-450B-A134-5977B391DC7DQ34453057-816E9F12-D7F4-48F5-845E-630ED1817B18Q34735417-F4DF0880-3624-4881-ABB8-17D3D7B9C9E3Q34981487-14BC0949-0298-4CE9-9B48-891811AC2AE3Q36066066-42703489-8657-4308-AC22-B2E5012AABE8Q36101317-662EE2D5-A499-4772-83D3-AFFBD5763755Q36121837-DA6ADEEF-1811-4012-A465-41C6DD2A2074Q36470218-F12EF1A4-476A-4078-8607-77717690843DQ36576972-DFA64A8A-6D11-4DAC-AB9B-268169C8C661Q36662350-D17078E5-21EE-4E7E-B269-1605BC09B46CQ36974613-9FE71EA5-6005-46ED-86CD-D14CB5A68A76Q37152990-E9E5830A-5858-401B-9D67-6B7622A69E60Q37157847-CC369E61-5498-4208-B237-490F346A7537Q37248844-4F63EE80-33E9-48FF-980C-622CDCB2EDE0Q37552845-3B23E705-F5E7-4B4B-9E1E-63A78F348015Q37685107-69C3BAB9-8A4D-43F7-BAAE-29F4EE2CEB38Q38056688-2CE16838-AE90-4349-8CA6-758630BC9DC8Q38311018-DB5B0B2B-6490-4995-BFBC-CC77EC64087DQ39669355-A17D844A-FD17-4247-9985-00606F04564CQ40120636-6D28D6F8-9F10-4DE0-8DA0-EA11D284C786Q40495056-DF6B9958-81FD-42BB-8183-D399EC84B2C2Q41230950-5F6468D6-2F50-472B-8BBE-0D745CB314D7Q45081199-BA68772D-7564-4E64-8063-D5D4EDD6279BQ46324029-7E1F3EBF-D5A1-4F53-91E3-0DBB9C9AE46DQ46608256-8FA039C9-7B3F-4A6B-9795-699E9A6B8C79Q47138937-46132C98-3959-43B0-8A76-8B94C35BA1F3Q54236411-FB4CF9A7-B27F-4B0D-BD5D-EF800BAB5CDAQ55093494-91758B7E-382C-4416-883E-C15EB79CBF15Q57146773-F68D0034-DFFC-4A6C-BC5A-BE414E0B8243Q58787560-AA9A88F9-4AA0-4C73-99F2-898FA04CB075
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Proteomics analysis of human cerebrospinal fluid.
@ast
Proteomics analysis of human cerebrospinal fluid.
@en
type
label
Proteomics analysis of human cerebrospinal fluid.
@ast
Proteomics analysis of human cerebrospinal fluid.
@en
prefLabel
Proteomics analysis of human cerebrospinal fluid.
@ast
Proteomics analysis of human cerebrospinal fluid.
@en
P1476
Proteomics analysis of human cerebrospinal fluid.
@en
P2093
Dominic M Desiderio
Xianglin Yuan
P304
P356
10.1016/J.JCHROMB.2004.06.044
P577
2005-02-01T00:00:00Z